GAL-001: Adaptive Phase II in Refractory Melanoma · Phase II
Mount Halifax Oncology Center · Dr. A. Reyes
consented 2026-05-26
AEs
0
Serious
0
Dropout signal
+0.25
☾ Luna — Jonah Reyes
granted
💬 2
⚠ 2 escalations
mood ø 2.0
meds 14%
📅 Cycle 3 infusion — NXC-101 on 2026-08-23
Adverse events
No adverse events recorded.
Data queries
No data queries.